PSNL
Personalis, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 28 to Jun 4 ▼ 3 days of insider sells: $2.0M by 2 insiders, avg $11.36
- Jun 26 to Jun 29 ▼ 2 days of insider sells: $2.1M by 2 insiders, avg $13.19
- Jul 9 to Jul 15 ▼ 2 days of insider sells: $3.0M by 2 insiders, avg $15.12
- Jul 20 Trading halt: Trading Halt: PSNL, T1 (News Pending)
- Jul 20 ▲ Personalis (PSNL) entered into a definitive merger agreement with Te…
- Jul 20 ▲ Tempus AI (TEM) announced a definitive agreement to acquire Personal…
- Jul 20 ▲ Personalis (PSNL) announced a definitive agreement to be acquired by…
- Aug 9 ▲ Six institutional investors accumulated $16.2M in Personalis (PSNL)…
- Sep 18 ▼ 4 insiders sell $266.9K at $16.22
- Oct 2 ▲ This Amendment No. 1 to the Schedule 13E-3 updates the going-private…
- Oct 6 ▼ BTIG downgrades
- Nov 3 ▼ 1 insider sell $462.0K at $15.87
Signal stack
Where each data set points today.
- InsidersBEARISH
4 insiders sold $7.8M.
- InstitutionsBULLISH
Q3 2026: 27 added (2 new), 17 trimmed or exited. Largest new: Sculptor Capital $14.7M.
- AnalystsBULLISH
6 of 11 rate it Buy or better. Median target $16.25 (+10%).
- EstimatesFLAT
Current-quarter EPS estimate −$0.237 → −$0.233 over 90 days. 1 up, 0 down in 30 days.
- Short sellersSTEADY
Short interest −0.7% to 6.75M shares. 3.3 days to cover, ≈6.2% of shares.
- TrendDOWNTREND
8% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Aberdeen Group plc | ADD | $148.6M |
| Qube Research & Technologies Ltd | DOUBLED | $35.6M |
| Nuveen, LLC | DOUBLED | $25.9M |
| Sculptor Capital LP | NEW | $14.7M |
| MORGAN STANLEY | TRIM | $10.0M |
| Jump Financial, LLC | DOUBLED | $5.7M |
| MARSHALL WACE, LLP | DOUBLED | $5.0M |
| HRT FINANCIAL LP | NEAR_EXIT | $3.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analystsPrice is inside the target range. Median implies +10%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 6, 2026 | BTIG DOWNGRADE | Neutral |
| Jul 20, 2026 | Lake Street DOWNGRADE | Hold |
| Jul 20, 2026 | BTIG MAINTAIN | Buy |
| Jul 20, 2026 | Needham DOWNGRADE | Hold |
| Jul 17, 2026 | Needham MAINTAIN | Buy |
| Jul 9, 2026 | Morgan Stanley MAINTAIN | Equal-Weight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Hall Christopher M Chief Executive Officer Nov 3, 2026 | SELL | $462.0K |
Tachibana Aaron CFO AND COO Sep 18, 2026 | SELL | $47.5K |
Hall Christopher M Chief Executive Officer Sep 18, 2026 | SELL | $121.0K |
Chen Richard President and CMO Sep 18, 2026 | SELL | $64.8K |
Moore Stephen Michael SVP and Chief Legal Officer Sep 18, 2026 | SELL | $33.5K |
Chen Richard President and CMO Jul 15, 2026 | EXERCISE | $244.0K |
Chen Richard President and CMO Jul 15, 2026 | SELL | $1.5M |
Hall Christopher M Chief Executive Officer Jul 9, 2026 | EXERCISE | $161.0K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.23 | -$0.31–-$0.20 | +1.8% | $25.2M |
| Next Q | -$0.23 | -$0.25–-$0.22 | +0.0% | $23.2M |
| Current FY | -$1.16 | -$1.21–-$1.10 | -6.9% | $88.7M |
| Next FY | -$0.98 | -$1.18–-$0.84 | -4.5% | $110.5M |
Washington
Short side
FINRA· Oct 30, 2026| Jul 20, 2026 | Resumption Scheduled | Resumed |
SecBot reports
29 filings · 6 bullish · 3 bearish · 20 neutral- NEUTRAL SC 13G/ANov 16, 2026
Ameriprise Financial filed an amended Schedule 13G disclosing a 1.0% passive stake in Personalis as of September 30, 2026, representing 1,107,803 shares. This is a routine passive update with no material change in position, filed in the context of the pending Tempus acquisition.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL SC 13G/ANov 13, 2026
ARK Investment Management and Catherine Wood filed Amendment No. 8 to Schedule 13G, reporting a…
Monitor for any conversion of this 13G to a 13D if ARK shifts to an activist stance, though the current filing explicitly disclaims control intent. The pending Tempus acquisition is the primary…
- NEUTRAL 425Nov 12, 2026
Personalis filed an investor presentation urging stockholders to vote FOR the pending acquisition…
The stockholder vote on November 30 is the next key catalyst. Monitor for any dissident stockholder opposition or regulatory developments that could affect deal closure.
- NEUTRAL 425Nov 6, 2026
Personalis filed another Rule 425 communication urging stockholders to vote FOR the pending…
Monitor stockholder vote outcome on November 30, 2026; the deal's completion depends on Personalis stockholder approval and customary closing conditions.
All PSNL filing & press-release reports (29)
- SC 13G/A reportNov 16, 2026
- SC 13G/A reportNov 13, 2026
- 425 reportNov 12, 2026
- 425 reportNov 6, 2026
- 8-K reportNov 4, 2026
- 425 reportNov 3, 2026
- 425 reportOct 30, 2026
- DEFM14A reportOct 21, 2026
- 425 reportOct 20, 2026
- 425 reportOct 20, 2026
- SC 13E-3/A reportOct 20, 2026
- 425 reportOct 6, 2026
- 8-K reportOct 6, 2026
- SC 13E-3/A reportOct 2, 2026
- CLUSTER reportSep 22, 2026
- INST-CLUSTER reportAug 9, 2026
- 425 reportJul 20, 2026
- 8-K reportJul 20, 2026
- 425 reportJul 20, 2026
- 8-K reportJul 20, 2026
- CLUSTER reportJul 15, 2026
- 144 reportJun 26, 2026
- 144 reportJun 29, 2026
- 144 reportJun 26, 2026
- CLUSTER reportJun 5, 2026
- 144 reportJun 4, 2026
- CLUSTER reportMay 29, 2026
- 144 reportMay 29, 2026
- 144 reportMay 28, 2026